Vertex Pharmaceuticals
VRTX
#202
Rank
C$149.71 B
Marketcap
C$588.58
Share price
-1.11%
Change (1 day)
-14.53%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2025 (TTM): C$6.44 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are C$12.00 Billion. , an increase over its 2024 earnings that were of C$0.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 C$6.36 B1568.4%
2024 C$0.38 B-93.69%
2023 C$6.05 B3.19%
2022 C$5.86 B53.56%
2021 C$3.81 B-12.06%
2020 C$4.34 B118.45%
2019 C$1.98 B120.64%
2018 C$0.90 B1473.64%
2017 C$57.26 M197.6%
2016 C$19.24 M-102.97%
2015 -C$0.65 Billion-28.46%
2014 -C$0.91 Billion-51.5%
2013 -C$1.87 Billion-30584.68%
2012 C$6.12 M-95.47%
2011 C$0.13 B
2009 -C$0.82 Billion
2007 -C$0.57 Billion83.1%
2006 -C$0.31 Billion59.02%
2005 -C$0.2 Billion3.28%
2004 -C$0.19 Billion-38.16%
2003 -C$0.31 Billion
2000 -C$52.04 Million-20.38%
1999 -C$65.36 Million31.62%
1998 -C$49.66 Million91.05%
1997 -C$25.99 Million-36.24%
1996 -C$40.77 Million12.45%
1995 -C$36.25 Million27.4%
1994 -C$28.46 Million-1833.33%
1993 C$1.64 M-112.12%
1992 -C$13.55 Million175%
1991 -C$4.93 Million-12.2%
1990 -C$5.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$45.89 B 620.54%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$9.02 B 41.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$13.40 B 110.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$30.67 B 381.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$12.75 B 100.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-C$0.11 Billion-101.63%๐Ÿ‡บ๐Ÿ‡ธ USA